Display options
Cite
Singh S, Loftus EV. Management of severe steroid-refractory ulcerative colitis: cyclosporine or infliximab?. Gastroenterology. 2013;144(5):1138-40doi: 10.1053/j.gastro.2013.03.037.
Singh, S., & Loftus, E. V. (2013). Management of severe steroid-refractory ulcerative colitis: cyclosporine or infliximab?. Gastroenterology, 144(5), 1138-40. https://doi.org/10.1053/j.gastro.2013.03.037
Singh, Siddharth, and Loftus, Edward V. "Management of severe steroid-refractory ulcerative colitis: cyclosporine or infliximab?." Gastroenterology vol. 144,5 (2013): 1138-40. doi: https://doi.org/10.1053/j.gastro.2013.03.037
Singh S, Loftus EV. Management of severe steroid-refractory ulcerative colitis: cyclosporine or infliximab?. Gastroenterology. 2013 May;144(5):1138-40. doi: 10.1053/j.gastro.2013.03.037. Epub 2013 Mar 23. PMID: 23528662.
Copy Download .nbib Format: NLM
Share it on

Gastroenterology. 2013 May;144(5):1138-40. doi: 10.1053/j.gastro.2013.03.037. Epub 2013 Mar 23.

Management of severe steroid-refractory ulcerative colitis: cyclosporine or infliximab?.

Gastroenterology

Siddharth Singh, Edward V Loftus

Affiliations

  1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

PMID: 23528662 DOI: 10.1053/j.gastro.2013.03.037

[No abstract available.]

Publication Types